These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 22227864

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.
    Manfredi R, Calza L.
    AIDS Patient Care STDS; 2008 Apr; 22(4):279-90. PubMed ID: 18290748
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck.
    Valley-Omar Z, Sibeko S, Anderson J, Goodier S, Werner L, Arney L, Naranbhai V, Treurnicht F, Abrahams MR, Bandawe G, Swanstrom R, Karim QA, Karim SS, Williamson C.
    J Infect Dis; 2012 Jul 01; 206(1):35-40. PubMed ID: 22551813
    [Abstract] [Full Text] [Related]

  • 25. A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel.
    Schwartz JL, Rountree W, Kashuba AD, Brache V, Creinin MD, Poindexter A, Kearney BP.
    PLoS One; 2011 Jul 01; 6(10):e25974. PubMed ID: 22039430
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits.
    Clark MR, Friend DR.
    AIDS Res Hum Retroviruses; 2012 Nov 01; 28(11):1458-66. PubMed ID: 22394281
    [Abstract] [Full Text] [Related]

  • 27. A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection.
    Gengiah TN, Baxter C, Mansoor LE, Kharsany AB, Abdool Karim SS.
    Expert Opin Investig Drugs; 2012 May 01; 21(5):695-715. PubMed ID: 22394224
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir.
    Clark JT, Johnson TJ, Clark MR, Nebeker JS, Fabian J, Tuitupou AL, Ponnapalli S, Smith EM, Friend DR, Kiser PF.
    J Control Release; 2012 Oct 28; 163(2):240-8. PubMed ID: 22981701
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV prevention.
    Akil A, Agashe H, Dezzutti CS, Moncla BJ, Hillier SL, Devlin B, Shi Y, Uranker K, Rohan LC.
    Pharm Res; 2015 Feb 28; 32(2):458-68. PubMed ID: 25079391
    [Abstract] [Full Text] [Related]

  • 32. Impact of Tenofovir gel as a PrEP on HIV infection: a mathematical model.
    Rahman SM, Vaidya NK, Zou X.
    J Theor Biol; 2014 Apr 21; 347():151-9. PubMed ID: 24380779
    [Abstract] [Full Text] [Related]

  • 33. Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.
    Dobard CW, Taylor A, Sharma S, Anderson PL, Bushman LR, Chuong D, Pau CP, Hanson D, Wang L, Garcia-Lerma JG, McGowan I, Rohan L, Heneine W.
    J Infect Dis; 2015 Dec 15; 212(12):1988-95. PubMed ID: 26071566
    [Abstract] [Full Text] [Related]

  • 34. Assessing adherence in the CAPRISA 004 tenofovir gel HIV prevention trial: results of a nested case-control study.
    MacQueen KM, Weaver MA, van Loggerenberg F, Succop S, Majola N, Taylor D, Karim QA, Karim SA.
    AIDS Behav; 2014 May 15; 18(5):826-32. PubMed ID: 24647763
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Preformulation and development of a once-daily sustained-release tenofovir vaginal tablet tablet containing a single excipient.
    Mcconville C, Friend DR, Clark MR, Malcolm K.
    J Pharm Sci; 2013 Jun 15; 102(6):1859-1868. PubMed ID: 23568749
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.